Sorilux FDA Approved Drugs
CALCIPOTRIENE [CalcipotrieneC27H40O3]
RX
- 0.005% (topical solution)
Fougera PharmsMay 6, 2008
G And W Labs IncMar 24, 2011
Glenmark PharmsJun 9, 2015
Glenmark Pharms IncMar 24, 2010
Hi Tech PharmaNov 19, 2009
TolmarMay 30, 2012
G And W Labs IncMar 24, 2011
Glenmark PharmsJun 9, 2015
Glenmark Pharms IncMar 24, 2010
Hi Tech PharmaNov 19, 2009
TolmarMay 30, 2012
SORILUX [CalcipotrieneC27H40O3]
RX
- 0.005% (topical aerosol, foam)
Mayne PharmaOct 6, 2010
- Use of a calcipotriene containing foam for the treatment of psoriasis.
- Use of calcipotriene foam for the topical treatment of plaque psoriasis in patients aged 18 years and older.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.